Open AccessReview
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
by
Emanuele Monda, Giuseppe Palmiero, Michele Lioncino, Marta Rubino, Annapaola Cirillo, Adelaide Fusco, Martina Caiazza, Federica Verrillo, Gaetano Diana, Alfredo Mauriello, Michele Iavarone, Maria Angela Losi, Maria Luisa De Rimini, Santo Dellegrottaglie, Antonello D’Andrea, Eduardo Bossone, Giuseppe Pacileo and Giuseppe Limongelli
Cited by 21 | Viewed by 5136
Abstract
Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of
[...] Read more.
Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.
Full article
►▼
Show Figures